OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Multi-year agreement with five-year initial term and option to extend Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has expanded its strategic partnership with Bristol Myers Squibb (“BMS”) (NYSE: BMY), signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS' CAR-T programmes. This expanded partnership builds on the existing relationship with Bristol Myers Squibb, originally announced in March 2020 Under the new agreement, OXB is expected to commence commercial manufacturing in 2026, subject to regulatory approval of the relevant CAR-T products. Manufacturing will take place at OXB's facilities in Oxford, UK, and Durham NC, US. The CSA is expected to generate meaningful multi-year revenue and supports the Company's existing medium-term financial guidance, demonstrating further successful execution of OXB's focused cell and gene therapy CDMO st
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- TrumpRx, the prescription drug website, set to launch [USA TODAY]USA TODAY
- We're increasing our price target on Bristol Myers after earnings and guidance top forecasts [CNBC]CNBC
- Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025 [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb in charts: Q4 revenue from Eliquis, Opdivo, Yervoy, Orencia rises Y/Y; Sprycel and Pomalyst/ Imnovid falls [Seeking Alpha]Seeking Alpha
- Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025Business Wire
BMY
Earnings
- 2/5/26 - Beat
BMY
Sec Filings
- 2/5/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- BMY's page on the SEC website